Efficacy of Direct-Acting Antivirals in Patients with Hepatitis C Virus/Human Immunodeficiency Virus Coinfection: A Gap between Clinical Trial and Real Practice

참고문헌 (10)

1. Limketkai BN, "Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV", HCV, 2012, pp.308, 370~378
2. Chung RT, "Peginterferon alfa- 2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons", N Engl J Med, 351, pp.451~459 (2004)
3. Carrat F, "Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial", JAMA, 292, pp.2839~2848 (2004)
4. Naggie S, "Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1", N Engl J Med, 373, pp.705~713 (2015)
5. Wyles DL, "Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1", N Engl J Med, 373, pp.714~725 (2015)
6. Wyles D, "Sofosbuvir and velpatasvir for the treatment of hepatitis C virus in patients coinfected with human immunodeficiency virus type 1: an open-label, phase 3 study", Clin Infect Dis, 65, pp.6~12 (2017)
7. Rockstroh JK, "Efficacy and safety of glecaprevir", pibrentasvir in patients coinfected with hepatitis C virus and human immunodeficiency virus type 1: the EXPEDITION- 2 study, 2018, pp.67, 1010~1017
8. Neukam K, "HIVcoinfected patients respond worse to direct-acting antiviralbased therapy against chronic hepatitis C in real life than HCVmonoinfected individuals: a prospective cohort study", HIV Clin Trials, 18, pp.126~134 (2017)
9. Vijay Gayam, "Real-World Clinical Efficacy and Tolerability of Direct-Acting Antivirals in Hepatitis C Monoinfection Compared to Hepatitis C", Human Immunodeficiency Virus Coinfection in a Community Care Setting, 2018, pp.12(6), 694~703[DOI]
10. Montes ML, "Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection", AIDS, 31, pp.1253~1260 (2017)

관련 논문AI추천